Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer(Neo-Color)

PHASE2RecruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

March 31, 2029

Conditions
Colon Cancer
Interventions
RADIATION

radiotherapy

Radiotherapy: Administer three-dimensional conformal/intensity-modulated/TOMO radiotherapy with a conventional fractionation schedule of 36-41.4 Gy in 20-23 fractions (1.8 Gy per fraction).

DRUG

CAPOX

4 cycles, Oxaliplatin 130 mg/m², Capecitabine 825 mg/m²

DRUG

Capecitabine

Administer Capecitabine at a dose of 825 mg/m², twice daily, orally on radiotherapy days

DRUG

Iparomlimab and Tuvonralimab Injection

IV, 5 mg/kg every 3 weeks

Trial Locations (1)

050000

RECRUITING

the Fourth Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

Hebei Medical University Fourth Hospital

OTHER